Univ.-Prof. Dipl.-Ing. Dr. Manfred Ogris
Summer term 2024
321014 VO Anatomie und Physiologie - B8
321026 VU Pharmazeutisches Imaging - B13 - (5 Kurse)
321031 PR Biochemische und vertiefende pharmazeutisch-chemische Arbeitstechniken - B17 - (5 Kurse)
321126 VU Pharmazeutisches Imaging - B13 - Zusatzkurse - (2 Kurse)
323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
580003 SE SE Journal Club: biochemistry
Winter term 2023
321002 VO Steop Biologie für PharmazeutInnen - B2
321026 VU Pharmazeutisches Imaging - B13 - (5 Kurse)
321031 PR Biochemische und vertiefende pharmazeutisch-chemische Arbeitstechniken - B17 - (6 Kurse)
321126 VU Pharmazeutisches Imaging - B13 - Zusatzkurse - (2 Kurse)
323005 VO Preclinical Drug Development - MPS4
580006 SE SE Journal Club: biochemistry
Summer term 2023
321026 VU Pharmazeutisches Imaging - B13 - (5 Kurse)
321031 PR Biochemische und vertiefende pharmazeutisch-chemische Arbeitstechniken - B17 - (6 Kurse)
321126 VU Pharmazeutisches Imaging - B13 - Zusatzkurse - (2 Kurse)
323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
580003 SE SE Journal Club: biochemistry
Kasper JC, Schaffert D, Ogris M, Wagner E, Friess W. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability-A step closer from promising technology to application. Journal of Controlled Release. 2011 May 10;151(3):246-255. doi: 10.1016/j.jconrel.2011.01.003
Klutz K, Schaffert D, Willhauck MJ, Gruenwald GK, Haase R, Wunderlich N et al. Epidermal Growth Factor Receptor-targeted I-131-therapy of Liver Cancer Following Systemic Delivery of the Sodium Iodide Symporter Gene. Molecular Therapy. 2011 Apr;19(4):676-685. doi: 10.1038/mt.2010.296
Schaffert D, Kiss M, Roedl W, Shir A, Levitzki A, Ogris M et al. Poly(I: C)-Mediated Tumor Growth Suppression in EGF-Receptor Overexpressing Tumors Using EGF-Polyethylene Glycol-Linear Polyethylenimine as Carrier. Pharmaceutical Research. 2011 Apr;28(4):731-741. doi: 10.1007/s11095-010-0225-4
Shir A, Ogris M, Roedl W, Wagner E, Levitzki A. EGFR-Homing dsRNA Activates Cancer-Targeted Immune Response and Eliminates Disseminated EGFR-Overexpressing Tumors in Mice. Clinical Cancer Research. 2011 Mar 1;17(5):1033-1043. doi: 10.1158/1078-0432.CCR-10-1140
Stahnke S, Lux K, Uhrig S, Kreppel F, Hoesel M, Coutelle O et al. Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles. Virology. 2011 Jan 5;409(1):77-83. doi: 10.1016/j.virol.2010.09.025
Kasper JC, Schaffert D, Ogris M, Wagner E, Friess W. The establishment of an up-scaled micro-mixer method allows the standardized and reproducible preparation of well-defined plasmid/LPEI polyplexes. European Journal of Pharmaceutics and Biopharmaceutics. 2011 Jan;77(1):182-185. doi: 10.1016/j.ejpb.2010.11.012
Magnusson T, Haase R, Schleef M, Wagner E, Ogris M. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations. Journal of Gene Medicine. 2011;13(7-8):382-391. doi: 10.1002/jgm.1585
Terziyska N, Farkasova K, Wagner E, Ogris M, Jeremias I. In Vivo Imaging In the Individualized Mouse Model of Acute Lymphoblastic Leukemia Enables Highly Sensitive and Continuous Follow up of Patient-Derived Xenografts. Blood. 2010 Nov 19;116(21):1336-1336.
Rupprecht S, Hagedorn C, Seruggia D, Magnusson T, Wagner E, Ogris M et al. Controlled removal of a nonviral episomal vector from transfected cells. Gene. 2010 Oct 15;466(1-2):36-42. doi: 10.1016/j.gene.2010.07.001
Gruenwald GK, Klutz K, Willhauck MJ, Wunderlich N, Senekowitsch-Schmidtke R, Ogris M et al. An alpha-Fetoprotein Promoter Driven, Conditionally Replicating Adenovirus that Expresses the Sodium Iodide Symporter (NIS) for Radiovirotherapy of HCC. Human Gene Therapy. 2010 Sep;21(9):1184-1184.
Espenlaub S, Corjon S, Engler T, Fella C, Ogris M, Wagner E et al. Analysis of Intracellular Particle Trafficking and Bioresponsive Bonds for Ad Vector Shielding by Capsomer-Specific Fluorescent Labeling. Human Gene Therapy. 2010 Sep;21(9):1179-1179.
Espenlaub S, Corjon S, Engler T, Fella C, Ogris M, Wagner E et al. Capsomer-Specific Fluorescent Labeling of Adenoviral Vector Particles Allows for Detailed Analysis of Intracellular Particle Trafficking and the Performance of Bioresponsive Bonds for Vector Capsid Modifications. Human Gene Therapy. 2010 Sep;21(9):1155-1167. doi: 10.1089/hum.2009.171
Vetter A, Virdi KS, Espenlaub S, Roedl W, Wagner E, Holm PS et al. Chemical Modification of the Adenovirus Capsid for Enhanced Viral Uptake into Target Cells. Human Gene Therapy. 2010 Sep;21(9):1193-1193.
Kasper JC, Schaffert D, Ogris M, Wagner E, Friess W. Development of a Stable Lyophilized Formulation for LPEI Polyplexes. Human Gene Therapy. 2010 Sep;21(9):1189-1189.
Koenig FM, Ruthardt N, Wagner E, Ogris M, Braeuchle C. EGF Receptor Targeting of Polyplexes with the Short Artificial Peptide GE11 Studied by Live Cell Imaging. Human Gene Therapy. 2010 Sep;21(9):1180-1181.
Haase R, Magnusson T, Wagner E, Ogris M. Generation of the Novel, Synthetic Hybrid SCE-Promoter for Gene-Therapeutical Applications. Human Gene Therapy. 2010 Sep;21(9):1190-1190.
Cengizeroglu A, Farkasova K, Deutsch D, Haase R, Anton M, Wagner E et al. Harnessing Molecular Targets in Human Colon Cancer Cells for Tumor Specific RNAi and pDNA-Based Therapies. Human Gene Therapy. 2010 Sep;21(9):1205-1205.
Farkasova K, Cengizeroglu A, Haase R, Anton M, Ellwart J, Wagner E et al. Luciferase-Based Dual Bioluminescence Imaging of Tumor Metastases After Systemic Transgene Delivery with a Synthetic Gene Carrier. Human Gene Therapy. 2010 Sep;21(9):1186-1186.
Klutz K, Schaffert D, Gruenwald GK, Willhauck MJ, Roedl W, Wunderlich N et al. Radioiodine Therapy of HCC Following Systemic Sodium Iodide Symporter (NIS) Gene Transfer Using EGF-Receptor Targeted Nonviral Gene Delivery Vectors. Human Gene Therapy. 2010 Sep;21(9):1207-1208.
Su B, Wagner E, Ogris M. TNF Alpha Gene Therapy Synergizes with Liposomal Doxorubicin in the Treatment of Experimental Neuroblastoma and Hepatoma in Mice. Human Gene Therapy. 2010 Sep;21(9):1204-1205.
Water-soluble NHC stabilized Gold Nanoparticles
Michael Reithofer (Speaker), Jia Min Chin (Contributor), Adam J. Young (Speaker), Haider Sami (Contributor), Constantin Eisen (Contributor), Guilherme Rubio (Contributor), Nathalie Tepe (Contributor), Thilo Hofmann (Contributor), Manfred Ogris (Contributor) & Bernhard Keppler (Contributor)
11 Aug 2019
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Department of Pharmaceutical Sciences
Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D450
T: +43-1-4277-55551